What is it about?

The main objective of this study was to evaluate in a swine acute myocardial infarction model the safety and efficacy of an intracoronary injection of two different doses of allogeneic porcine cardiac stem cells (pCSCs).

Featured Image

Why is it important?

A slight increase in Tpn I was observed after cell/vehicle delivery without significant differences between groups. Higher EF and lower EDV and ESV values were found in the pCSC-treated animals compared to controls (table). The histological study revealed a greater extension of fibrosis in the control pigs.

Read the Original

This page is a summary of: SAFETY AND EFFICACY ASSESSMENT OF INTRACORONARY DELIVERY OF PORCINE CARDIAC STEM CELLS IN A SWINE MODEL OF ACUTE MYOCARDIAL INFARCTION: COMPARISON OF TWO DIFFERENT CELL DOSES, Journal of the American College of Cardiology, April 2014, Elsevier,
DOI: 10.1016/s0735-1097(14)61763-0.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page